Search results for: 'Small Molecule Contract Development and Manufacturing Organization'

This research service provides an analysis of various aspects of the cardiac patient monitoring market in Central and Eastern European countries for the period between 2010 and 2016. The market has been divided into five segments: resting ECG, stress ECG, ECG Holter monitors, cardiac event recorders, and data management systems (DMS). The study cov...

The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources remain persistent challenges for the diagnostics sector. Automation, a broad concept encompassing processes and practices that streamline workflows, save time, and manage increasing workloads, has become a key response to these issues. By combining ...

The infrastructure industry in the KSA, which enjoyed high growth rates over the last few years, is facing hardships due to crude oil prices. This in turn has affected the demand for paints and coatings. However, the Government's plans for economic diversification will serve as a shot in the arm for the paints and coatings industry. Development of...

Stringent European emission norms dictate that automotive Original Equipment Manufacturers (OEMs) comply with the carbon emission target of 95g/km by 2020 and the indicative range of 68–78 g/km by 2025. While OEMs have been focusing on improving efficiency, there is a growing preference among consumers for vehicles that offer better ride and handli...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

29 Jun 2023  |  Global  |  Technology Research

Emerging Landscape of Targeted Protein Degradation Therapeutics

Rapid Technology Advances Bolster a Robust Therapeutic Pipeline

Infographics

×

This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80%...

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...

Robotic-assisted surgical devices (RASDs) have transformed surgical practice by enhancing precision, dexterity, and control during complex procedures. Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Pay-per-use models or leasing options can alleviate concerns about high acquisition and maintenance co...

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...